Abbott Obtains Rights to Distribute Biofortuna HLA-typing Kits

Upon regulatory approvals, Abbott will have exclusive distribution rights in the US and all other geographies, excluding France, Spain, Portugal, and the Benelux countries.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories